Q: Can you comment on the prospects and yield for this new listing
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hello 5i,
Us health and cad health stocks give me a headache ! My list of dogs is long and they bite. I’ve even held ibb for three years and sold it at a loss in December! (Gain on the currency- only).
1) should I keep ILMN after this most recent report or technically is it too about to bite?
2) not including big pharma, is there a US asset 5i can suggest that is not too expensive yet shows promise?
Thank you!
Us health and cad health stocks give me a headache ! My list of dogs is long and they bite. I’ve even held ibb for three years and sold it at a loss in December! (Gain on the currency- only).
1) should I keep ILMN after this most recent report or technically is it too about to bite?
2) not including big pharma, is there a US asset 5i can suggest that is not too expensive yet shows promise?
Thank you!
Q: Hi 5i,
I know that US stocks are not the main focus but I have been watching Resmed for awhile and saw that it tanked 20% the other day on an off earnings report. This looks to have been a fairly strong stock over the last few years. Any comments you can make on them? Would they fit in your US growth stock list?
Thank you
I know that US stocks are not the main focus but I have been watching Resmed for awhile and saw that it tanked 20% the other day on an off earnings report. This looks to have been a fairly strong stock over the last few years. Any comments you can make on them? Would they fit in your US growth stock list?
Thank you
Q: Hello,
Could you please comments on MKSI Q4 results and outlook. Do you think if it is worth hold? If not, could you please recommend two US stocks in semi sector.
Thanks
Victor
Could you please comments on MKSI Q4 results and outlook. Do you think if it is worth hold? If not, could you please recommend two US stocks in semi sector.
Thanks
Victor
Q: Your thoughts on GE earnings?
Q: I have a question about 461 still a buy.thanks
Q: I have a question about GLW. It had a nice 11% pop yesterday. Can you enlighten me as to what drove this ?
Q: What's your opinion on CARVANA?
NYSE: CVNA
NYSE: CVNA
Q: Hi I am holding some TSLA shares which are underwater. Given the latest financial report and CFO's retirement, the stock is further down. Should I cut it ASAP or wait for a better opportunity?
Q: 5I Team,
I know that US equities isn't your bailiwick, but I would appreciate any comments you may have on Akoustis Technologies Inc. (NASDAQ: AKTS).
Thanks
I know that US equities isn't your bailiwick, but I would appreciate any comments you may have on Akoustis Technologies Inc. (NASDAQ: AKTS).
Thanks
Q: ISRG was down about 4% Friday on general concerns about spending and increased competition from J&J and Google amongst others. I’m not sure what the fuss is all about since competition is just a fact of life and to the best of my knowledge neither J&J nor Google have any experience building medical devices.
It’s reported ISRG earned $2.96 a share, missing expectations by 2-11 cents per share. However ISRG reported profit was cut by 16 cents per share due to a payment to the Intuitive Foundation. Is the foundation part of the research arm of ISRG and why a foundation? Would ISRG have exceeded expectations if they hadn’t payed money to the foundation and did the analysis’s anticipate the donation to the the foundation?
I am contemplating buying the dip a little bit or do you think I should hold off?
Thanks for you prompt response on Conmed! (I don’t count the weekend as part of the 36 hour commitment).
Jim
It’s reported ISRG earned $2.96 a share, missing expectations by 2-11 cents per share. However ISRG reported profit was cut by 16 cents per share due to a payment to the Intuitive Foundation. Is the foundation part of the research arm of ISRG and why a foundation? Would ISRG have exceeded expectations if they hadn’t payed money to the foundation and did the analysis’s anticipate the donation to the the foundation?
I am contemplating buying the dip a little bit or do you think I should hold off?
Thanks for you prompt response on Conmed! (I don’t count the weekend as part of the 36 hour commitment).
Jim
Q: How concerned would you be about Nvidia's revenue guidance warning if you were planning to hold it for at least 3-5 years, and do you think this could be a bad harbinger for the tech sector as a whole near-term?
Q: With revenue guidance released today missing expectations, would you still be comfortable with this? I noticed the stock was still a suggestion on another question this morning, but wasn't sure if that came before or after guidance was provided.
Q: Hi 5iResearch Team,
Just wondering what impact would the slow down in China's economy have on NVDA. Your thoughts on this and the company as whole going forward, would be much appreciated.
Cheers,
Just wondering what impact would the slow down in China's economy have on NVDA. Your thoughts on this and the company as whole going forward, would be much appreciated.
Cheers,
Q: I have some extra cash to deploy for US growth stocks, how would you rank these when it comes to the best opportnity for purchase right now?
Thanks,
Thanks,
Q: as you know square received a significant downgrade today, last week it had an upgrade.
what i do not understand in todays downgrade he talks negatively about them getting a bank license, i thought this is a positive.
what is your opinion of this downgrade, do you agree.
dave
what i do not understand in todays downgrade he talks negatively about them getting a bank license, i thought this is a positive.
what is your opinion of this downgrade, do you agree.
dave
Q: I initiated a position in both of these companies (<2%) at the beginning of January and am down 7% on NVDA and up 15% in SQ. Both have been under considerable down pressure recently. Would you continue to hold or liquidate at until the dust settles.
Thanks Kindly.
Thanks Kindly.
Q: Based on recent Q4 revenue warning and analysts downgrades, Nvidia's stock price continues to drop. How do you feel about it's prospects going forward and if positive, would this be a good time to buy or should I wait out the negative sentiment?
Q: Hello,
Raymond James analyst downgraded SQ to underperform. "In short, we believe organic growth peaked in 3Q18 and growth on the all-important [subscription] and services line will likely materially decelerate in 2Q19. What do you think about this opinion? Do you still think its a buy?
Thanks
Victor
Raymond James analyst downgraded SQ to underperform. "In short, we believe organic growth peaked in 3Q18 and growth on the all-important [subscription] and services line will likely materially decelerate in 2Q19. What do you think about this opinion? Do you still think its a buy?
Thanks
Victor
Q: What is your current view on GrubHub? I like the company. The stock has been pretty beaten up. Is it a buy, hold or sell?